Brenntag (BNR) PT Set at €52.50 by UBS Group

Brenntag (FRA:BNR) has been given a €52.50 ($61.05) price target by stock analysts at UBS Group in a research report issued on Thursday, Borsen Zeitung reports. The firm presently has a “buy” rating on the stock. UBS Group’s price objective would indicate a potential upside of 16.67% from the stock’s current price.

BNR has been the topic of a number of other research reports. Nord/LB set a €47.00 ($54.65) target price on Brenntag and gave the company a “neutral” rating in a report on Tuesday, March 12th. Goldman Sachs Group set a €55.00 ($63.95) target price on Brenntag and gave the company a “buy” rating in a report on Wednesday, March 6th. Baader Bank set a €50.00 ($58.14) target price on Brenntag and gave the company a “buy” rating in a report on Friday, January 18th. Kepler Capital Markets set a €56.00 ($65.12) target price on Brenntag and gave the company a “buy” rating in a report on Thursday, April 4th. Finally, Independent Research set a €50.00 ($58.14) target price on Brenntag and gave the company a “neutral” rating in a report on Wednesday, March 6th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Brenntag currently has an average rating of “Buy” and an average target price of €53.64 ($62.38).

FRA:BNR opened at €45.00 ($52.33) on Thursday. Brenntag has a 12-month low of €43.06 ($50.07) and a 12-month high of €56.25 ($65.41).

About Brenntag

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.

Recommended Story: What is an Initial Public Offering (IPO)?

Analyst Recommendations for Brenntag (FRA:BNR)

Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.